Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: In silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique

Journal of Chemical Information and Modeling

Volumn 46, Issue 3, 2006, Pages 1491-1502

  Hattotuwagama, Channa K ^a   Toseland, Christopher P ^a   Guan, Pingping ^a   Taylor, Debra J ^a   Hemsley, Shelley L ^a   Doytchinova, Irini A ^a   Flower, Darren R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; CHEMICAL BONDS; COMPUTER SOFTWARE; HISTOLOGY; ITERATIVE METHODS; MATHEMATICAL MODELS;

MULTIVARIATE STATISTICAL TECHNIQUE; PARTIAL-LEAST-SQUARES (PLS); PEPTIDES; SOFTWARE PACKAGE;

PROTEINS;

HLA ANTIGEN CLASS 2;

ANIMAL; ARTICLE; BIOLOGY; CHEMISTRY; MOUSE; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS;

ANIMALS; COMPUTATIONAL BIOLOGY; HISTOCOMPATIBILITY ANTIGENS CLASS II; LEAST-SQUARES ANALYSIS; MICE; MULTIVARIATE ANALYSIS;

EID: 33745360682     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci050380d     Document Type: Article

References (91)

1. Rudensky, A. Y.; Preston-Hurlburt, P.; Hong, S.-C.; Buus, S.; Tschinke, V. Predicting binding affinities of protein ligands from three-dimensional: application to peptide bound to class I MHC class II molecules. Nature 1991, 353, 622-627.
2. Hunt, D. F.; Michel, H.; Dickinson, T. A.; Shabanowitz, J.; Cox, A. L.; Sakaguchi, K.; Appella, E. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science. 1992, 256, 1817-1820.
3. Chicz, R. M.; Urban, R. G.; Lane, W. S.; Gorga, J. C.; Stern, L. J.; Vignali, D. A. A.; Strominger, J.L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992, 358, 764-768.
4. Chicz, R. M.; Urban, R. G.; Gorga, J. C.; Vignali, D. A. A.; Lane, W. S.; Strominger, J. L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 1993, 178, 27-47.
5. Dessen, A.; Lawrence, C. M.; Cupo, S.; Zaller, D. M.; Wiley, D. C. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB*0401) complexed with a peptide from human collagen II. Immunity 1997, 7, 473-481.
6. Hennecke, J.; Wiley, D. C. Structure of a complex of the human α/β T cell receptor (TCR) HA 1.7, influenza hemaglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 2002, 195, 571-581.
7. Doytchinova, I. A.; Flower, D. R. Towards the in silico identification of class II restricted T cell epitopes: a partial least squares iterative self-consistent algorithm for affinity prediction. Bioinformatics 2003, 19, 1-8.
8. Doytchinova, I. A.; Blythe, M. J.; Flower, D. R. Additive method for the prediction of protein-peptide binding affinity. Application to the MHC class I molecule HLA-A*0201. J. Proteome Res. 2002, 1, 263-272.
9. Guan, P.; Doytchinova, I. A.; Flower, D. R. HLA-A3 supermotif defined by quantitative structure-activity relationship analysis. Protein Eng. 2003, 16, 11-18.
10. Blythe, M.; Doytchiniva, I. A.; Flower, D. R. JenPep: a database of quantitative functional peptide data for immunology. Bioinformatics 2002, 18, 434-439.
11. McSparron, H.; Blythe, M. J.; Zygouri, C.; Doytchinova, I. A.; Flower, D. R. JenPep: A novel computational information resource for immunology and vaccinology. J. Chem. Inf. Comput. Sci. 2003, 43, 1276-1287.
12. Ruppert, J.; Sidney, J.; Celis, E.; Kubo, R. T.; Grey, H. M.; Sette, A. Prominent role of secondary anchor residues in peptide binding to HLA-A*0201 molecules. Cell 1993, 74, 929-937.
13. Sette, A.; Sidney, J.; del Guercio, M.-F.; Southwood, S.; Ruppert, J.; Dalberg, C.; Grey, H. M.; Kubo, R. T. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol. Immunol. 1994, 31, 813-822.
14. Wold, S. PLS for multivariate linear modelling. In Chemometric Methods in Molecular Design; van de Waterbeemd, H., Ed.; VCH: Weinheim, Germany, 1995; pp 195-218.
15. SYBYL, version 6.9; Tripos Inc.: St. Louis, MO.
16. Brett, S. J.; Cease, K. B.; Ouyang, C. S.; Berzofsky, J. A. Fine specificity of T cell recognition of the same peptide in association with different I-A molecules. J. Immunol. 1989, 143, 771-779.
17. Berkower, I.; Buckenmeyer, G. K.; Berzofsky, J. A. Molecular mapping of a histocompatibility-restricted immunodominant T cell epitope with synthetic and natural peptides: implications for T cell antigenic structure. J. Immunol. 1986, 136, 2498-503.
18. Nalefski, E. A.; Rao, A. Nature of the ligand recognized by a hapten-and carrier-specific, MHC-restricted T cell receptor. J. Immunol. 1993, 150, 3806-3816.
19. Ffrench, R. A.; Tang, X. L.; Anders, E. M.; Jackson, D. C.; White, D. O.; Drummer, H.; Wade, J. D.; Tregear, G. W.; Brown, L. E. Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus. J. Virol. 1989, 63, 3087-3094.
20. Robertson, J. M.; Jensen, P. E.; Evavold, B. D. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J. Immunol. 2000, 164, 4706-4712.
21. Delvig, A. A.; Rosenqvist, E.; Oftung, F.; Robinson, J. H. T-Cell epitope mapping the PorB protein of serogroup B Neisseria meningitidis in B10 congenic strains of mice. Clin. Immunol. Immunopathol. 1997, 85, 134-142.
22. Wen, R.; Surman, S.; Blackman, M. A.; Woodland, D. L. The conventional CD4+ T cell response to staphylococcal enterotoxin B is modified by its superantigenic activity. Cell Immunol. 1997, 176, 166-172.
23. Targoni, O. S.; Lehmann, P. V. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 1998, 187, 2055-2063.
24. Decker, P.; Le Moal, A.; Briand, J. P.; Muller, S. Identification of a minimal T cell epitope recognized by antinucleosome Th cells in the C-terminal region of histone H4. J. Immunol. 2000, 165, 654-662.
25. Nagabhushanam, V.; Purcell, A. W.; Mannering, S.; Germano, S.; Praszkier, J.; Cheers, C. Identification of an I-Ad restricted peptide on the 65-kilodalton heat shock protein of Mycobacterium avium. Immunol. Cell Biol. 2002, 80, 574-583.
26. Williams, K. M.; Bigley, E. C, III. Identification of an I-Ed-restricted T-cell epitope of Escherichia coli outer membrane protein. Infect. Immun. 2004, 72, 3907-3913.
27. Gugasyan, R.; Velazquez, C.; Vidavsky, I.; Deck, B. M.; van der Drift, K.; Gross, M. L.; Unanue, E. R. Independent selection by I-Ak molecules of two epitopes found in tandem in an extended polypeptide antigen. J. Immunol. 2000, 165, 3206-3213.
28. van Stipdonk, M. J.; Willems, A. A.; Amor, S.; Persoon-Deen, C.; Travers, P. J.; Boog, C. J.; van Noort, J. M. T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen. Int. Immunol. 1998, 10, 943-950.
29. Luescher, I. F.; Allen, P. M.; Unanue, E. R. Binding of photoreactive lysozyme peptides to murine histocompatibility class II molecules. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 871-874.
30. Mills, K. H.; Burt, D. S.; Skehel, J. J.; Thomas, D. B. Fine specificity of murine class II-restricted T cell clones for synthetic peptides of influenza virus hemagglutinin. Heterogeneity of antigen interaction with the T cell and the la molecule. J. Immunol. 1988, 140, 4083-4090.
31. Adorini, L.; Sette, A.; Buus, S.; Grey, H. M.; Darsley, M.; Lehmann, P. V.; Doria, G.; Nagy, Z. A.; Appella, E. Interaction of an immunodominant epitope with la molecules in T-cell activation. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 5181-5185.
32. Latek, R. R.; Petzold, S. J.; Unanue, E. R. Hindering auxiliary anchors are potent modulators of peptide binding and selection by I-Ak class II molecules. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 11460-11465.
33. Nelson, C. A.; Roof, R. W.; McCourt, D. W.; Unanue, E. R. Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 7380-7383.
34. Maecker, H. T.; Umetsu, D. T.; DeKruyff, R. H.; Levy, S. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. J. Immunol. 1998, 161, 6532-6536.
35. Hernandez, H. J.; Stadecker, M. J. Elucidation and role of critical residues of immunodominant peptide associated with T cell-mediated parasitic disease. J. Immunol. 1999, 163, 3877-3882.
36. Chen, J. S.; Lorenz, R. G.; Goldberg, J.; Allen, P. M. Identification and characterization of a T cell-inducing epitope of bovine ribonuclease that can be restricted by multiple class II molecules. J. Immunol. 1991, 147, 3672-3678.
37. Wall, K. A.; Hu, J.-Y.; Currier, P.; Southwood, S.; Sette, A.; Infante, A. J. A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism. J. Immunol. 1994, 152, 4526-4536.
38. Svensson, M.; Stockinger, B.; Wick, M. J. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J. Immunol. 1997, 158, 4229-4236.
39. Vacchio, M. S.; Berzofsky, J. A.; Krzych, U.; Smith, J. A.; Hodes, R. J.; Finnegan, A. Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones. J. Immunol. 1989, 143, 2814-2819.
40. Hsu, B. L.; Donermeyer, D. L.; Allen, P. M. TCR recognition of the Hb(64-76)/I-Ek determinant: single conservative amino acid changes in the complementarity-determining region 3 dramatically alter antigen fine specificity. J. Immunol. 1996, 157, 2291-2298.
41. Parra-Lopez, C. A.; Lindner, R.; Vidavsky, I.; Gross, M.; Unanue, E. R. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway. J. Immunol. 1997, 158, 2670-2679.
42. Nikcevich, K. M.; Kopielski, D.; Finnegan, A. Interference with the binding of a naturally processed peptide to class II alters the immunodominance of T cell epitopes in vivo. J. Immunol. 1994, 153, 1015-1026.
43. Chianese-Bullock, K. A.; Russell, H. I.; Moller, C.; Gerhard, W.; Monaco, J. J.; Eisenlohr, L. C. Antigen processing of two H2-IEd-restricted epitopes is differentially influenced by the structural changes in a viral glycoprotein. J. Immunol. 1998, 161, 1599-1607.
44. Kang, H. K.; Mikszta, J. A.; Deng, H.; Sercarz, E. E.; Jensen, P. E.; Kim, B. S. Processing and reactivity of T cell epitopes containing two cysteine residues from hen egg-white iysozyme (HEL74-90). J. Immunol. 2000, 164, 1775-1782.
45. Lovitch, S. B.; Petzold, S. J.; Unanue, E. R. Cutting edge: H-2DM is responsible for the large differences in presentation among peptides selected by I-Ak during antigen processing. J. Immunol. 2003, 171, 2183-2186.
46. Viner, N. J.; Nelson, C. A.; Unanue, E. R. Identification of a major I-Ek-restricted determinant of hen egg lysozyme: limitations of lymph node proliferation studies in defining immunodominance and crypticity. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 2214-2218.
47. Boots, A. M.; Kusters, J. G.; van Noort, J. M.; Zwaagstra, K. A.; Rijke, E.; van der Zeijst, B. A.; Hensen, E. J. Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus. Immunology 1991, 74, 8-13.
48. Nelson, C. A.; Viner, N.; Young, S.; Petzold, S.; Benoist, C.; Mathis, D.; Unanue, E. R. Amino acid residues on the I-Ak alpha-chain required for the binding and stability of two antigenic peptides. J. Immunol. 1996, 156, 176-182.
49. d molecules in the activation of MHC class II-restricted T cells. J. Immunol. 1991, 147, 198-204.
50. Shi, Y.; Kaliyaperumal, A.; Lu, L.; Southwood, S.; Sette, A.; Michaels, M. A.; Datta, S. K. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor a chain. J. Exp. Med. 1998, 187, 367-378.
51. Bhayani, H.; Carbone, F. R.; Paterson, Y. The activation of pigeon cytochrome c-specific T cell hybridomas by antigenic peptides is influenced by non-native sequences at the amino terminus of the determinant. J. Immunol. 1988, 141, 377-382.
52. Diment, S. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. J. Immunol. 1990, 145, 417-422.
53. Guery, J. C.; Adorini, L. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J. Immunol. 1995, 154, 536-544.
54. London, C. A.; Perez, V. L.; Abbas, A. K. Functional characteristics and survival requirements of memory CD4+ T lymphocytes in vivo. J. Immunol. 1999, 162, 766-773.
55. Boeckmann, B.; Bairoch, A.; Apweiler, R.; Blatter, M. C.; Estreicher, A.; Gasteiger, E.; Martin, M. J.; Michoud, K.; O'Donovan, C.; Phan, I.; Pilbout, S.; Schneider, M. The SWISS-PROT protein knowledge-base and its supplement TrEMBL in 2003. Nucleic Acids Res. 2003, 31, 365-370.
56. Reche, P. A.; Glutting, J. P.; Reinherz, E. L. Prediction of MHC class I binding peptides using profile motifs. Hum. Immunol. 2002, 63, 701-709.
57. Reche, P. A.; Glutting, J. P.; Zhang, H.; Reinherz, E. L. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 2004, 56, 405-419.
58. Naujokas, M. F.; Southwood, S.; Mathies, S. J.; Appella, E.; Sette, A.; Miller, J. T cell recognition of flanking residues of murine invariant chain-derived CLIP peptide bound to MHC class II. Cell. Immunol. 1998, 188, 49-54.
59. Sant'Angelo, D. B.; Robinson, E.; Janeway, C. A., Jr.; Denzin, L. K. Recognition of core and flanking amino acids of MHC class II bound peptides by the T cell receptor. Eur. J. Immunol. 2002, 32, 2510-2521.
60. Alexander, J.; Sidney, J.; Southwood, S.; Ruppert, J.; Oseroff, C.; Maewal, A.; Snoke, K.; Serra, H. M.; Kubo, R. T.; Sette, A.; Grey, H. M. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1994, 1, 751-761.
61. Pfeiffer, C.; Stein, J.; Southwood, S.; Ketelaar, H.; Sette, A.; Bottomly, K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 1995, 181, 1569-1574.
62. Sette, A.; Southwood, S.; Miller, J.; Appella, E. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 1995, 181, 677-683.
63. Livingston, B.; Crimi, C.; Newman, M.; Higashimoto, Y.; Appella, E.; Sidney, J.; Sette, A. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J. Immunol. 2002, 168, 5499-5506.
64. Tsunoda, I.; Sette, A.; Fujinami, R. S.; Oseroff, C.; Ruppert, J.; Dahlberg, C.; Southwood, S.; Arrhenius, T.; Kuang, L.-Q.; Kubo, R. T.; Chesnut, R. W.; Ishioka, G. Y. Lipopeptide particles as the immunologically active component of CTL inducing vaccines. Vaccine 1999, 17, 675-685.
65. g7, the MHC class II molecule that protects Eα-transgenic nonobese diabetic mice from autoimmune diabetes. J. Immunol. 1999, 162, 6630-6640.
66. Hill, J. A.; Wang, D.; Jevnikar, A. M.; Cairns, E.; Bell, D. A. The relationship between predicted peptide-MHC class II affinity and T cell activation in a HLA-DRβ1*0401 transgenic mouse model. Arthritis Res. Ther. 2002, 5, R40-R48.
67. Cucca, F.; Lampis, R.; Congia, M.; Angius, E.; Nutland, S.; Bain, S. C.; Barnett, A. H.; Todd, J. A. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins. Hum. Mol. Genet. 2001, 10, 2025-2037.
68. Brown, J. H.; Jardetzky, T. S.; Stern, L. J.; Gorga, J. C.; Strominger, J. L.; Wiley, D. C. Human class II MHC molecule HLA-DR1: X-ray structure determined from three crystal forms. Acta Crystallogr., Sect D 1995, D51, 946-961.
69. Rammesee, H.-G.; Bachmann, J.; Emmerich, N. P. N.; Bachor, O. A.; Stevanovic, S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50, 213-219.
70. Rammesee, H.-G.; Friede, T.; Stevanovic, S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995, 41, 178-228.
71. k. J. Immunol. 1996, 157, 755-762.
72. Schild, H.; Gruneberg, U.; Pougialis, G.; Wallny, H. J.; Keilholz, W.; Stevanovic, S.; Rammensee, H. G. Natural ligand motifs of H-2E molecules are allele specific and illustrates homology to HLA-DR molecules. Int. Immunol. 1995, 7, 1957-1965.
73. Reay, P. A.; Kantor, R. M.; Davis, M. M. Use of global amino acid replacement to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 1994, 152, 3946-3957.
74. Marrack, P.; Ignatowicz, L.; Kappler, J. W.; Boymel, J.; Freed, J. H. Comparison of peptides bound to spleen and thymus class II. J. Exp. Med. 1993, 178, 2173-2183.
75. Flower, D. R.; Doytchinova, I. A.; Paine, K.; Taylor, P.; Lamponi, D.; Zygouri, C.; Guan, P.; McSparron, H.; Kirkbride, H. Computational vaccine design. Drug Design: Cutting Edge Approaches; Royal Society of Chemistry: Cambridge, U. K., 2002; p 136.
76. Fremont, D. H.; Monnaie, D.; Nelson, C. A.; Hendrickson, W. A.; Unanue, E. R. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity 1998, 8, 305-317.
77. g7 and autoimmune diabetes. Science 2000, 288, 505-511.
78. 2 proteins. J. Mol. Biol. 2000, 304, 177-188.
79. McFarland, B. J.; Sant, A. J.; Lybrand, T. P.; Beeson, C. Ovalbumin (323-339) peptide bind to the major histocompatibility complex class II, I-A(d) protein using two functionally distinct registers. Biochemistry 1999, 38, 16663-16670.
80. Vidal, K.; Daniel, C.; Vidavsky, I.; Nelson, C. A.; Allen, P. M. Hb (64-76) epitope binds in different registers and lengths to I-Ek and I-Ak. Mol. Immunol. 2000, 37, 203-212.
81. Bankovich, A. J.; Girvin, A. T.; Moesta, A. K.; Garcia, K. C. Peptide register shifting within the MHC groove: theory becomes reality. Mol. Immunol. 2004, 40, 1033-1039.
82. Xia, J.; Sollid, L. M.; Khosla, C. Equilibrium and Kinetic Analysis of the Unusual Binding Behavior of a Highly Immunogenic Gluten Peptide to HLA-DQ2. Biochemistry 2005, 44, 4442-4449.
83. Hecht, C. E. Statistical Thermodynamics and Kinetic Theory; WH Freeman: New York, 1990.
84. He, X. L.: Radu, C.; Sidney, J.; Sette, A.; Ward, E. S.; Garcia, K. C. Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au. Immunity 2002, 17, 83-94.
85. Doytchinova, I. A.; Walshe, V.; Jones, N.; Gloster, S.; Borrow, P.; Flower, D. R. Coupling in silico and in vitro analysis of peptide-MHC binding: a bioinformatic approach enabling prediction of superbinding peptides and anchorless epitopes. J. Immunol. 2004, 172, 7495-7502.
86. Flower, D. R. Towards in silico prediction of immunogenic epitopes. Trends Immunol. 2003, 24, 667-674.
87. b. PNAS 2002, 99, 8820-8825.
88. Arnold, P. Y.; La Gruta, N. L.; Miller, T.; Vignali, K. M.; Adams, P. S.; Woodland, D. L.; Vignali, D. A. The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues. J. Immunol. 2002, 169, 739-749.
89. Guan, P.; Doytchinova, I. A.; Zygouri, C.; Flower, D. R. MHCPred: bringing a quantitative dimension to the online prediction of MHC binding. Appl. Bioinformatics 2003, 2, 63-66.
90. Guan, P.; Doytchinova, I. A.; Zygouri, C.; Flower, D. R. MHCPred: a server for quantitative prediction of peptide-MHC binding. Nucleic Acids Res. 2003, 31, 3621-3624.
91. Hattotuwagama, C. K.; Guan, P.; Doytchinova, I. A.; Zygouri, C.; Flower, D. R. Quantitative online prediction of peptide binding to the major histocompatibility complex. J. Mol. Grapics Modell. 2004, 22, 195-207.